Why AstraZeneca and Surface Oncology Rose Today

·2-min read
Why AstraZeneca and Surface Oncology Rose Today

The pharmaceutical giant reports encouraging results from a late-stage ES-SCLC trial of blockbuster cancer treatment Imfinzi.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting